6 Ultra-High-Yield Names Where Coverage Is Cracking
A 29% yield sounds like a retirement dream until you look at what the coverage math actually says. Six popular high-yield names are flashing warning signs that patient investors can no longer afford to ignore.
A yield above the market average can be a reward for patient capital or a signal that other investors are pricing in a coming cut. Icahn Enterprises (NASDAQ:IEP | IEP Price Prediction), for example, screens at a distribution yield of 29.3%, a level the market almost never hands out for free. For retirement-focused readers, the point of a screen is to separate a durable payout from one that is being propped up by falling share prices, new debt, or new share issuance.
A dividend looks unsustainable when the right coverage metric (EPS for corporates, FFO or NFFO for property REITs, distributable earnings for mortgage REITs, distributable cash flow for MLPs) fails to cover the payout, when free cash flow lags, or when leverage is rising to hold the line. Here are six ultra-high-yield names where at least one of those signals is flashing.
Arbor Realty Trust (NYSE: ABR)
Arbor Realty Trust (NYSE:ABR) is a multifamily-focused commercial mortgage REIT trading at $4.76, down 53.65% over the past year. That price collapse is what makes the trailing yield look generous.
The correct coverage metric here is distributable earnings versus the dividend. Arbor already cut the quarterly payout to $0.17 from $0.30, and even so, distributable earnings fell to $0.10 per diluted share from $0.25 a year earlier, meaning the reduced dividend still is not covered. Credit stress is building: 19 non-performing loans with $428.8 million unpaid principal balance and a $38.2 million net provision for credit losses. Management itself flagged that “GAAP net loss indicating distributable earnings may not cover dividend over time.”
Medical Properties Trust (NYSE: MPW)
Medical Properties Trust (NYSE:MPW) pays a $0.09 quarterly dividend, already deeply reduced from historical levels. The right coverage metric for a hospital net-lease REIT is NFFO, which came in at $0.15 per share for Q2 2026.
Leverage sits at 8.9x adjusted net debt/EBITDAre with interest coverage of just 1.9x, and the company just issued $2.4 billion of secured notes at a 9.25% coupon to push maturities to 2032. That coupon ratchets interest expense sharply higher. Tenant risk remains live: “It’s still in the 80s” is how the CFO described HSA cash collections. Asset sales are funding the plan, and management said “There’s no assurance that these transactions will be completed.”
Icahn Enterprises (NASDAQ: IEP)
Icahn Enterprises reaffirmed a $0.50 per depositary unit distribution, down from $2 in 2022 and $1 through mid-2024. The correct MLP coverage measure is distributable cash flow, and adjusted EBITDA attributable to IEP swung to a $134 million loss from a $40 million gain a year earlier.
Indicative NAV fell $765 million to about $2.6 billion in one quarter, and holding-company cash and equivalents dropped to $1.22 billion, off 67.74% year over year. The company itself notes subsidiary results “may not be sufficient to make distributions to parent.” The pending $700 million Pep Boys sale is earmarked partly for 2027 notes maturities rather than being available for the payout. A scrip default election on the payout is itself a cash-conservation signal.
ARMOUR Residential REIT (NYSE: ARR)
ARMOUR Residential REIT (NYSE:ARR) pays $0.24 monthly, or $2.88 annualized. The relevant metric is distributable earnings, and Q2 came in at $0.72 per share, exactly matching the quarterly dividend run rate. There is no cushion.
Debt-to-equity sits at 7.54:1, and the company continues to fund the payout through dilution, raising $218.7 million via common ATM in Q2 plus roughly $88.3 million more through July 14. ARR’s monthly amount has been reset from $0.40 to $0.08 between 2023-12-14 and 2023-09-14, among other prior cuts. Monthly frequency has not prevented substantial reductions.
Orchid Island Capital (NYSE: ORC)
Orchid Island Capital (NYSE:ORC) trimmed its monthly payout to $0.10 beginning with the 2026-04-30 ex-dividend date, down from $0.12. The dividend history shows repeated resets, including a step down to $0.045 in 2022.
Management said current leverage supports returns “approximately equal to our current dividend yield expressed as a percentage of book value per share, at approximately 16.5% to 17.0%”, a high hurdle if spreads narrow. Orchid sold 18,558,681 shares in H1 2026 for roughly $135.5 million via ATM, the classic agency mREIT pattern of issuing to fund the payout. Portfolio effective duration rose to 3.180 from 2.513, raising rate sensitivity.
AGNC Investment (NASDAQ: AGNC)
AGNC Investment (NASDAQ:AGNC) has held its monthly dividend at $0.12 since April 2020, following a long series of prior reductions from $0.22 in 2014-2015 down through $0.20, $0.18, $0.16, and finally $0.12. That is a stagnant payout after repeated cuts.
The Q2 beat leaned on a $461 million gain on interest rate swaps, a hedging tailwind rather than core spread income. AGNC also issued 16.2 million common shares for $167 million in Q2, funding part of the distribution with equity. Repo maturity averages just 13 days, leaving book value acutely sensitive to rate moves.
How Income Investors Should Treat Yields This High
Income investors should treat any yield in the high teens or above as a hypothesis to be disproven by coverage math. When a dividend is trimmed, the share price usually goes with it, so the paper yield rarely protects the total return. Verify distributable earnings, NFFO, or distributable cash flow against the payout, check whether ATM issuance is doing the heavy lifting, and demand a genuine cushion. Yield alone is never a buy thesis.
If a double-digit yield makes you nervous for exactly the reasons above, you are not alone. We cataloged the seven warning signs that a big payout is about to be cut in a free report you can grab here: Dividend Traps.
Contact [email protected] for any questions or corrections.







